July 2022 - Page 4 of 4 - BioMedWire (BMW)

TuesdayJul 05, 2022 1:55 pm

New Study Finds That Probiotics May Be Useful in Fight Against Depression

Gut biome, or the community of bacteria that live in the digestive tract, plays a significant role in overall health. If the balance of healthy and unhealthy bacteria in the stomach and intestines gets out of balance, individuals are likely to develop a variety of issues, including high blood sugar, weight gain and high cholesterol. According to a study that was recently published in the “Translation Psychiatry” journal, there may be a link between gut bacteria and mental health. The study found that probiotics, which consist of “good bacteria” that can benefit the digestive system, can be used to alleviate…

FridayJul 01, 2022 10:43 am

Exploring Why Women Have Heightened Risk of Developing Long COVID Infections

As the coronavirus pandemic raged on and millions of people across the world became infected with the virus, it became clear that for some people, the symptoms of COVID did not abate after a few weeks. Rather, these individuals experienced a variety of symptoms for months after their initial diagnosis, a phenomenon that was soon dubbed long COVID. Additionally, it seemed like women had a heightened risk of experiencing long COVID than men. This is despite the fact that previous research had shown men’s immune systems to be weaker against the coronavirus compared to women. Researchers looking into the prevalence…

FridayJul 01, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Reports Positive Findings on Phase 1 Clinical Trials of PRV-002 for Concussions

No adverse reactions were reported in any of the healthy subjects enrolled in the Cohort II Phase 1 clinical trial of PRV-002 Company in talks with military training sites for Phase 2 and 3 clinical trials on concussed patients The CDC estimates that approximately 1.6 to 3.8 million sports and recreation-related concussions occur annually, for which there is no FDA-approved treatment The global concussion market size was valued at $6.8 billion in 2019. This value is expected to rise to $8.9 billion by 2027, growing at a CAGR of 3.6% Odyssey Health (OTC: ODYY), a medical company focused on unique,…